Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Low Social Media Profile Keeps OTC Switches Out Of Conversations

This article was originally published in The Tan Sheet

Executive Summary

OTC marketers should promote benefits of OTC switches in social and traditional media, says Edelman PR Managing Director Peter Segall. Speaking at CHPA’s conference, he said companies must also tie switches and OTCs generally into online self-care searches.

You may also be interested in...



Manufacturing, Advertising Coalition Tackles Digital Ad-Block Devastation

P&G and Unilever work with Google and advertising experts worldwide to form the Coalition for Better Ads aiming for new online advertising standards. The coalition has not yet determined whether Google would provide better placement for ads complying with the standards.

Manufacturing, Advertising Coalition Tackles Digital Ad-Block Devastation

P&G and Unilever work with Google and advertising experts worldwide to form the Coalition for Better Ads aiming for new online advertising standards. The coalition has not yet determined whether Google would provide better placement for ads complying with the standards.

MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In

The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS107594

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel